Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

26
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
26
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

50
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
50
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

54
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
54
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

89
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
89
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

42
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Chill packs" self-administered olanzapine as psychiatric harm reduction for methamphetamine-induced psychosis: a narrative review of the existing evidence base.

Harm reduction journal·2026
Same author

Post-Traumatic Stress Disorder, Anxiety, and Depression in Patients after Undergoing Cesarean Hysterectomy for Placenta Accreta Spectrum Disorder.

American journal of perinatology·2026
Same author

Patterns of intravenous access used for labor and delivery at Society for Obstetric Anesthesia and Perinatology (SOAP) center of excellence designees: an international cross-sectional survey study (2025).

International journal of obstetric anesthesia·2026
Same author

High neuraxial block in obstetrics: are we only seeing the tip of the iceberg?

Anaesthesia·2025
Same author

Variation in Inpatient Admission for Management and Cost Drivers in Placenta Accreta Spectrum Disorder.

Obstetrics and gynecology·2025
Same author

Obstetric and perinatal management in the setting of cancer.

Seminars in perinatology·2025

Related Experiment Video

Updated: Sep 21, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

951

Preeclampsia diagnosis and management.

Eve Overton1, Daniel Tobes1, Allison Lee2

  • 1Columbia University Irving Medical Center, United States of America.

Best Practice & Research. Clinical Anaesthesiology
|June 6, 2022
PubMed
Summary

Preeclampsia, a severe pregnancy hypertension, risks maternal and fetal health. Magnesium therapy and blood pressure control are key treatments, requiring interdisciplinary management for optimal outcomes.

Keywords:
anesthetic managementeclampsiahypertensive disorders of pregnancymagnesiumpreeclampsiathrombocytopenia

More Related Videos

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
10:44

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function

Published on: June 2, 2019

6.0K
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

602

Related Experiment Videos

Last Updated: Sep 21, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

951
A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
10:44

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function

Published on: June 2, 2019

6.0K
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

602

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Cardiovascular Research

Background:

  • Preeclampsia affects 2-8% of pregnancies, posing severe maternal health risks.
  • Maternal complications include cerebral hemorrhage, pulmonary edema, acute kidney injury, hepatic issues, DIC, eclampsia, and placental abruption.
  • Fetal risks include preterm delivery, growth restriction, and placental abruption, increasing morbidity and mortality.

Purpose of the Study:

  • To summarize the critical aspects of preeclampsia management.
  • To highlight the severe maternal and fetal complications associated with preeclampsia.
  • To emphasize the importance of current treatment strategies and interdisciplinary care.

Main Methods:

  • Literature review of preeclampsia pathophysiology and management.
  • Analysis of maternal and fetal outcomes.
  • Synthesis of current treatment guidelines.

Main Results:

  • Preeclampsia is a significant cause of maternal and fetal morbidity and mortality.
  • Key maternal risks include organ damage and life-threatening events.
  • Fetal complications are often related to prematurity and placental insufficiency.

Conclusions:

  • Magnesium therapy for seizure prophylaxis and blood pressure control are essential treatments.
  • Interdisciplinary planning and management are crucial for optimizing patient and fetal outcomes.
  • Prompt recognition and management are vital to mitigate severe complications.